ICAHN CARL C
Institutional investor · Portfolio as of Q2 2020
Top Holdings16 positions
ICAHN ENTERPRISES LP | 205.1M | $9.9B | 50.4% | $14.78 | +0.23% | 7 qtrssince 2018-Q4 | Increased 68 |
OCCIDENTAL PETE CORP | 88.6M | $1.6B | 8.2% | $18.97 | -11.42% | 5 qtrssince 2019-Q2 | Unchanged 0 |
HERBALIFE LTD | 35.2M | $1.6B | 8.0% | $58.20 | -24.02% | 7 qtrssince 2018-Q4 | Unchanged 0 |
CVR ENERGY INC | 71.2M | $1.4B | 7.3% | $19.52 | -34.50% | 7 qtrssince 2018-Q4 | Unchanged 0 |
| 114.3M | $1.4B | 7.0% | — | — | 6 qtrssince 2019-Q1 | Unchanged 0 | |
CHENIERE ENERGY INC | 20.8M | $1B | 5.1% | $55.31 | -16.89% | 7 qtrssince 2018-Q4 | Increased 67 |
NEWELL BRANDS INC | 43.7M | $694M | 3.5% | $13.04 | -6.37% | 7 qtrssince 2018-Q4 | Unchanged 0 |
CLOUDERA INC | 52.3M | $665.6M | 3.4% | — | — | 4 qtrssince 2019-Q3 | Decreased 0 |
NAVISTAR INTL CORP NEW | 16.7M | $471.8M | 2.4% | — | — | 7 qtrssince 2018-Q4 | Unchanged 0 |
XEROX HOLDINGS CORP | 23.5M | $358.6M | 1.8% | $21.07 | -47.70% | 4 qtrssince 2019-Q3 | Unchanged 0 |
DELEK US HLDGS INC NEW | 10.5M | $183.5M | 0.9% | $13.28 | +5.87% | 2 qtrssince 2020-Q1 | Unchanged 0 |
HERC HLDGS INC | 4.5M | $138.1M | 0.7% | $23.61 | +19.23% | 7 qtrssince 2018-Q4 | Unchanged 0 |
CONDUENT INC | 38.1M | $91.2M | 0.5% | $9.55 | -74.67% | 7 qtrssince 2018-Q4 | Unchanged 0 |
WELBILT INC | 11.9M | $72.7M | 0.4% | — | — | 7 qtrssince 2018-Q4 | Unchanged 0 |
| 9.1M | $69.1M | 0.4% | $9.68 | -11.88% | 7 qtrssince 2018-Q4 | Increased 54 | |
SANDRIDGE ENERGY INC | 4.8M | $6.2M | 0.0% | $5.53 | -83.54% | 7 qtrssince 2018-Q4 | Unchanged 0 |
ICAHN CARL C manages $19.7B across 16 positions as of Q2 2020. Top holdings: IEP (50.4%), OXY (8.2%), HLF (8.0%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4/5.0.
Exited 3, increased 3, trimmed 1. Top move: IEP (INCREASED, conviction 68). Portfolio: $19.7B across 16 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR